The relevance of pharmacognosy in pharmacological research on herbal medicinal products

Epilepsy and Behavior

Volumn 52, Issue , 2015, Pages 344-362

  Pferschy Wenzig, Eva Maria ^a   Bauer, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Herbal medicinal products; Pharmacognosy; Quality control

Indexed keywords

CARBAMAZEPINE; HERBACEOUS AGENT; PHOSPHODIESTERASE V INHIBITOR; VALPROIC ACID; PLANT MEDICINAL PRODUCT;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ATOMIC ABSORPTION SPECTROMETRY; CAPILLARY ELECTROPHORESIS; DISCRIMINANT ANALYSIS; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; ECONOMIC ASPECT; EPILEPSY; EUROPEAN MEDICINES AGENCY; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTER SIMPLE SEQUENCE REPEAT; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHARMACOGNOSY; PHYTOCHEMISTRY; POLLUTION; REVIEW; SIMPLE SEQUENCE REPEAT; SUPERCRITICAL FLUID EXTRACTION; TAXONOMY; TIME OF FLIGHT MASS SPECTROMETRY; X RAY FLUORESCENCE; ANIMAL; MEDICAL RESEARCH; PHYTOTHERAPY; PROCEDURES; STANDARDS;

ANIMALS; BIOMEDICAL RESEARCH; HERBAL MEDICINE; HUMANS; PHARMACOGNOSY; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 84947488063     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.05.037     Document Type: Review

References (216)

1. Sertürner F.W. Über das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandteile des Opiums. Ann Phys 1817, 25:56-90.
2. Kinghorn A.D., Pan L., Fletcher J.N., Chai H. The relevance of higher plants in lead compound discovery programs. J Nat Prod 2011, 74:1539-1555.
3. Sneader W. Drug discovery: a history 2005, Wiley, Hoboken, N.J.
4. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30years from 1981 to 2010. J Nat Prod 2012, 75:311-335.
5. David B., Wolfender J., Dias D.A. The pharmaceutical industry and natural products historical status and new trends. Phytochem Rev 2015, 14:299-315.
6. World Health Organization General guidelines for methodologies on research and evaluation of traditional medicine http://whqlibdoc.who.int/hq/2000/WHO_EDM_TRM_2000.1.pdf.
7. World Health Organization WHO traditional medicine strategy: 2014-2023 http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/.
8. Mosihuzzaman M., Choudhary M.I. Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC technical report). Pure Appl Chem 2008, 80.
9. Cordell G.A., Colvard M.D. Natural products and traditional medicine: turning on a paradigm. J Nat Prod 2012, 75:514-525.
10. Gertsch J. Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Planta Med 2011, 77:1086-1098.
11. Wagner H., Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16:97-110.
12. Ulrich-Merzenich G., Panek D., Zeitler H., Wagner H., Vetter H. New perspectives for synergy research with the "omic"-technologies. Phytomedicine 2009, 16:495-508.
13. Kong D., Li X., Zhang H. Where is the hope for drug discovery? Let history tell the future. Drug Discov Today 2009, 14:115-119.
14. Cordell G.A. Phytochemistry and traditional medicine - a revolution in process. Phytochem Lett 2011, 4:391-398.
15. Wiesner J., Knöss W. Future visions for traditional and herbal medicinal products - a global practice for evaluation and regulation?. J Ethnopharmacol 2014, 158(Pt B):516-518.
16. World Health Organization National policies on traditional medicine and regulation of herbal medicines. Report of a WHO global survey 2005, [http://apps.who.int/medicinedocs/en/d/Js7916e/].
17. Vlietinck A., Pieters L., Apers S. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med 2009, 75:683-688.
18. Zakaryan A., Martin I.G. Regulation of herbal dietary supplements: is there a better way?. Ther Innov Regul Sci 2012, 46:532-544.
19. Bent S., Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004, 116:478-485.
20. van Galen E. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe. J Ethnopharmacol 2014, 158(Pt B):498-502.
21. Claeson P. Requirements on efficacy of herbal medicinal products. J Ethnopharmacol 2014, 158(Pt B):463-466.
22. Kroes B.H. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. J Ethnopharmacol 2014, 158(Pt B):449-453.
23. Wiesner J. Challenges of safety evaluation. J Ethnopharmacol 2014, 158(Pt B):467-470.
24. Zhang J., Wider B., Shang H., Li X., Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med 2012, 20:100-106.
25. Rivera D., Allkin R., Obón C., Alcaraz F., Verpoorte R., Heinrich M. What is in a name? The need for accurate scientific nomenclature for plants. J Ethnopharmacol 2014, 152:393-402.
26. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993, 341:387-391.
27. USDA, ARS, National Genetic Resources Program Germplasm Resources Information Network (GRIN) [online database] URL:. http://www.ars-grin.gov/cgi-bin/npgs/html/index.pl?language=en.
28. Govindaraghavan S., Hennell J.R., Sucher N.J. From classical taxonomy to genome and metabolome: towards comprehensive quality standards for medicinal herb raw materials and extracts. Fitoterapia 2012, 83:979-988.
29. Reich E., Schibli A. High-performance thin-layer chromatography for the analysis of medicinal plants 2007, Thieme, New York.
30. Smillie T.J., Khan I.A. A comprehensive approach to identifying and authenticating botanical products. Clin Pharmacol Ther 2010, 87:175-186.
31. Glasl S. Hoodia: a herb used in South African traditional medicine - a potential cure for overweight? Pharmacognostic review of history, composition, health related claims, scientific evidence and intellectual property rights. Schweiz Zschr GanzheitsMedizin 2009, 21:300-306.
32. Vermaak I., Hamman J.H., Viljoen A.M. Hoodia gordonii: an up-to-date review of a commercially important anti-obesity plant. Planta Med 2011, 77:1149-1160.
33. Avula B., Wang Y., Pawar R.S., Shukla Y.J., Smillie T.J., Khan I.A. A rapid method for chemical fingerprint analysis of Hoodia species, related genera, and dietary supplements using UPLC-UV-MS. J Pharm Biomed Anal 2008, 48:722-731.
34. Jiang C., Cao L., Yuan Y., Chen M., Jin Y., Huang L. Barcoding melting curve analysis for rapid, sensitive, and discriminating authentication of saffron (Crocus sativus L.) from its adulterants. BioMed Res Int 2014, 2014:809037.
35. Torelli A., Marieschi M., Bruni R. Authentication of saffron (Crocus sativus L.) in different processed, retail products by means of SCAR markers. Food Control 2014, 36:126-131.
36. Petrakis E.A., Cagliani L.R., Polissiou M.G., Consonni R. Evaluation of saffron (Crocus sativus L.) adulteration with plant adulterants by (1)H NMR metabolite fingerprinting. Food Chem 2015, 173:890-896.
37. Yap K.Y., Chan S.Y., Lim C.S. Authentication of traditional Chinese medicine using infrared spectroscopy: distinguishing between ginseng and its morphological fakes. J Biomed Sci 2007, 14:265-273.
38. Kang J., Lee S., Kang S., Kwon H.N., Park J.H., Kwon S.W., et al. NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins. Arch Pharm Res 2008, 31:330-336.
39. Wang C., Ni M., Sun S., Li X., He H., Mehendale S.R., et al. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J Agric Food Chem 2009, 57:2363-2367.
40. Yu C., Wang C., Zhou C., Wang B., Han L., Zhang C., et al. Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysis. J Pharm Biomed Anal 2014, 99:8-15.
41. Sengupta S., Toh S., Sellers L.A., Skepper J.N., Koolwijk P., Leung H.W., et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004, 110:1219-1225.
42. Sievenpiper J.L., Arnason J.T., Leiter L.A., Vuksan V. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides. J Am Coll Nutr 2004, 23:248-258.
43. Samuels N., Finkelstein Y., Singer S.R., Oberbaum M. Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008, 49:373-380.
44. Ize-Ludlow D., Ragone S., Bruck I.S., Bernstein J.N., Duchowny M., Garcia Peña Barbara M. Neurotoxicities in infants seen with the consumption of star anise tea. Pediatrics 2004, 114:e653-e656.
45. Shen Y., van Beek Teris A., Claassen F.W., Zuilhof H., Chen B., Nielen Michel W.F. Rapid control of Chinese star anise fruits and teas for neurotoxic anisatin by direct analysis in real time high resolution mass spectrometry. J Chromatogr A 2012, 1259:179-186.
46. Vermaak I., Viljoen A., Lindström S.W. Hyperspectral imaging in the quality control of herbal medicines - the case of neurotoxic Japanese star anise. J Pharm Biomed Anal 2013, 75:207-213.
47. Vaclavik L., Krynitsky A.J., Rader J.I. Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: a review. Anal Bioanal Chem 2014, 406:6767-6790.
48. Patel D.N., Li L., Kee C., Ge X., Low M., Koh H. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J Pharm Biomed Anal 2014, 87:176-190.
49. Gilard V., Balayssac S., Tinaugus A., Martins N., Martino R., Malet-Martino M. Detection, identification and quantification by (1)H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal 2014, 102C:476-493.
50. Gur S., Kadowitz J.P., Gokce A., Sikka S.C., Lokman U., Hellstrom W.J.G. Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension. Curr Drug Metab 2013, 14:265-269.
51. U.S. Food and Drug Administration FDA approves Stendra for erectile dysfunction http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302140.htm.
52. Lau K.K., Lai C.K., Chan A.W. Phenytoin poisoning after using Chinese proprietary medicines. Hum Exp Toxicol 2000, 19:385-386.
53. Vines G. Herbal harvests with a future http://www.plantlife.org.uk/uploads/documents/Herbal-Harvests-with-a-Future.pdf.
54. Cordell G.A., Colvard M.D. Some thoughts on the future of ethnopharmacology. J Ethnopharmacol 2005, 100:5-14.
55. WWF Germany Harpagophytum ssp. downloaded from: WWF Artenlexikon [accessed 15.01.2014]. http://wwf.at/de/menu24/arten122/.
56. World Health Organization WHO guidelines on good agricultural and collection practices (GACP) http://whqlibdoc.who.int/publications/2003/9241546271.pdf.
57. EMA Committee on Herbal Medicinal Products (HMPC) Guideline on good agricultural and collection practice for starting materials of herbal origin http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003362.pdf.
58. Canter P.H., Thomas H., Ernst E. Bringing medicinal plants into cultivation: opportunities and challenges for biotechnology. Trends Biotechnol 2005, 23:180-185.
59. Martínez-Ballesta M.C., López-Pérez L., Hernández M., López-Berenguer C., Fernández-García N., Carvajal M. Agricultural practices for enhanced human health. Phytochem Rev 2008, 7:251-260.
60. Li H., Tsao R., Deng Z. Factors affecting the antioxidant potential and health benefits of plant foods. Can J Plant Sci 2012, 92:1101-1111.
61. Tanko H., Carrier D.J., Duan L., Clausen E. Pre- and post-harvest processing of medicinal plants. Plant Genetic Resources: Characterization and Utilization 2005, 3:304-313.
62. Mistríková I., Vaverková Š. Patterns of variation in lipophilic and hydrophilic constituents in flower developmental stages of Echinacea purpurea (L.) Moench cultivated in Slovakia. Plant Soil Environ 2009, 55:70-73.
63. Bauer R., vom Hagen-Plettenberg F. Proceedings of the "Fachtagung Arznei- und Gewürzpflanzen" in Giessen 1998.
64. Agneta R., Lelario F., de Maria S., Möllers C., Bufo S.A., Rivelli A.R. Glucosinolate profile and distribution among plant tissues and phenological stages of field-grown horseradish. Phytochemistry 2014, 106:178-187.
65. Galasso S., Pacifico S., Kretschmer N., Pan S., Marciano S., Piccolella S., et al. Influence of seasonal variation on Thymus longicaulis C. Presl chemical composition and its antioxidant and anti-inflammatory properties. Phytochemistry 2014, 107:80-90.
66. Pacifico S., Galasso S., Piccolella S., Kretschmer N., Pan S., Marciano S., et al. Seasonal variation in phenolic composition and antioxidant and anti-inflammatory activities of Calamintha nepeta (L.) Savi. Food Res Int 2015, 69:121-132.
67. Rieger G., Müller M., Guttenberger H., Bucar F. Influence of altitudinal variation on the content of phenolic compounds in wild populations of Calluna vulgaris, Sambucus nigra, and Vaccinium myrtillus. J Agric Food Chem 2008, 56:9080-9086.
68. Monschein M., Iglesias Neira J., Kunert O., Bucar F. Phytochemistry of heather (Calluna vulgaris (L.) Hull) and its altitudinal alteration. Phytochem Rev 2010, 9:205-215.
69. Grulova D., de Martino L., Mancini E., Salamon I., de Feo V. Seasonal variability of the main components in essential oil of Mentha×piperita L. J Sci Food Agric 2015, 95:621-627.
70. Tundis R., Statti G.A., Conforti F., Bianchi A., Agrimonti C., Sacchetti G., et al. Influence of environmental factors on composition of volatile constituents and biological activity of Helichrysum italicum (Roth) Don (Asteraceae). Nat Prod Res 2005, 19:379-387.
71. Fonseca J.M., Rushing J.W., Rajapakse N.C., Thomas R.L., Riley M.B. Phenolics and parthenolide levels in feverfew (Tanacetum parthenium) are inversely affected by environmental factors. J Appl Hortic 2008, 10:36-39.
72. Rocha R.P., Melo E.C., Radünz L.L. Influence of drying process on the quality of medicinal plants: a review. J Med Plants Res 2011, 5:7076-7084.
73. Sanzini E., Badea M., Santos A.D., Restani P., Sievers H. Quality control of plant food supplements. Food Funct 2011, 2:740-746.
74. Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002, 57:891-896.
75. Au A.M., Ko R., Boo F.O., Hsu R., Perez G., Yang Z. Screening methods for drugs and heavy metals in Chinese patent medicines. Bull Environ Contam Toxicol 2000, 65:112-119.
76. Yuan X., Chapman R.L., Wu Z. Analytical methods for heavy metals in herbal medicines. Phytochem Anal 2011, 22:189-198.
77. Gasser U., Klier B., Kühn A.V., Steinhoff B. Current findings on the heavy metal content in herbal drugs. Pharmeur Sci Notes 2009, 1:37-50.
78. Chizzola R., Michitsch H., Franz C. Monitoring of metallic micronutrients and heavy metals in herbs, spices and medicinal plants from Austria. Eur Food Res Technol 2003, 216:407-411.
79. Commission regulation (EC) no 629/2008 of 2 July 2008 amending regulation (EC) no 1881/2006 setting maximum levels for certain contaminants in foodstuffs. Off J Eur Union 2008, L 173/6.
80. World Health Organization WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues 2007, World Health Organization, Geneva.
81. European Pharmacopoeia 8th Main Edition 2014 2014, Verlag Österreich, Wein. 8th ed.
82. Kabelitz L., Sievers H. Contaminants of medicinal and food herbs with a view to EU regulations. Innov Food Technol 2004, 25-27.
83. Palmer P.T., Jacobs R., Baker P.E., Ferguson K., Webber S. Use of field-portable XRF analyzers for rapid screening of toxic elements in FDA-regulated products. J Agric Food Chem 2009, 57:2605-2613.
84. Reames G., Charlton V. Lead detection in food, medicinal and ceremonial items using a portable X-ray fluorescence (XRF) instrument. J Environ Health 2013, 75:16-20.
85. Mao X., Wan Y., Yan A., Shen M., Wei Y. Simultaneous determination of organophosphorus, organochlorine, pyrethriod and carbamate pesticides in Radix astragali by microwave-assisted extraction/dispersive-solid phase extraction coupled with GC-MS. Talanta 2012, 97:131-141.
86. Páleníková A., Martínez-Domínguez G., Arrebola F.J., Romero-González R., Hrouzková S., Frenich A.G. Multifamily determination of pesticide residues in soya-based nutraceutical products by GC/MS-MS. Food Chem 2015, 173:796-807.
87. Leung K.S., Chan K., Chan C., Lu G. Systematic evaluation of organochlorine pesticide residues in Chinese materia medica. Phytother Res 2005, 19:514-518.
88. Zuin V.G., Vilegas H.Y. Pesticide residues in medicinal plants and phytomedicines. Phytother Res 2000, 14:73-88.
89. Regulation (EC) no 396/2005 of the European parliament and of the council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. Off J Eur Union 2005, L 70/1.
90. Greenpeace South East Asia Chinese herbs: elixir of health or pesticide cocktail? http://www.greenpeace.org/international/Global/eastasia/publications/reports/food-agriculture/2013/chinese-herbs-pesticides-report.pdf.
91. Martínez-Domínguez G., Plaza-Bolaños P., Romero-González R., Garrido-Frenich A. Analytical approaches for the determination of pesticide residues in nutraceutical products and related matrices by chromatographic techniques coupled to mass spectrometry. Talanta 2014, 118:277-291.
92. Ashiq S., Hussain M., Ahmad B. Natural occurrence of mycotoxins in medicinal plants: a review. Fungal Genet Biol 2014, 66:1-10.
93. Trucksess M.W., Scott P.M. Mycotoxins in botanicals and dried fruits: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2008, 25:181-192.
94. Commission regulation (EU) no 165/2010 of 26 February 2010 amending regulation (EC) no 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards aflatoxins. Off J Eur Union 2010, L 50/8.
95. Commission regulation (EU) no 105/2010 of 5 February 2010 amending regulation (EC) no 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards ochratoxin A. Off J Eur Union 2010, L35/7.
96. Ishizaki A., Sito K., Kataoka H. Analysis of contaminant polycyclic aromatic hydrocarbons in tea products and crude drugs. Anal Methods 2011, 3:299.
97. Stevic T., Pavlovic S., Stankovic S., Savikin K. Pathogenic microorganisms of medicinal herbal drugs. Arch Biol Sci (Beogr) 2012, 64:49-58.
98. Cordell G.A. Phytochemistry and traditional medicine - the revolution continues. Phytochem Lett 2014, 28-40.
99. Gaedcke F., Phytopharmaka Steinhoff B. Wissenschaftliche und rechtliche Grundlagen für die Entwicklung, Standardisierung und Zulassung in Deutschland und Europa 2000, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, p 49.
100. Danlami J.M., Arsad A., Zaini MAA, Sulaiman H. A comparative study of various oil extraction techniques from plants. Rev Chem Eng 2014, 30:605-626.
101. Cintas P., Calcio-Gaudino E., Cravotto G. Pharmaceutical and nutraceutical compounds from natural matrices. Food engineering series 2013, 181-206. Springer US, Boston, MA. F. Chemat, G. Cravotto (Eds.).
102. Mason T.J., Chemat F., Vinatoru M. The extraction of natural products using ultrasound or microwaves. Curr Org Chem 2011, 15:237-247.
103. Herrero M., Castro-Puyana M., Mendiola J.A., Ibañez E. Compressed fluids for the extraction of bioactive compounds. TrAC Trends Anal Chem 2013, 43:67-83.
104. Capuzzo A., Maffei M.E., Occhipinti A. Supercritical fluid extraction of plant flavors and fragrances. Molecules 2013, 18:7194-7238.
105. Dong Tina T.X., Zhao K.J., Gao Q.T., Ji Z.N., Zhu T.T., Li J., et al. Chemical and biological assessment of a Chinese herbal decoction containing Radix astragali and Radix angelicae sinensis: determination of drug ratio in having optimized properties. J Agric Food Chem 2006, 54:2767-2774.
106. Chiu P.Y., Leung H.Y., Siu Ada H.Y., Poon Michel K.T., Dong Tina T.X., Tsim Karl W.K., et al. Dang-Gui Buxue Tang protects against oxidant injury by enhancing cellular glutathione in H9c2 cells: role of glutathione synthesis and regeneration. Planta Med 2007, 73:134-141.
107. Wölkart K., Gangemi D., Turner R., Bauer R. Enzymatic degradation of Echinacoside and cynarine in Echinacea angustifolia root preparations. Pharm Biol 2004, 42:443-448.
108. Nüsslein B., Kurzmann M., Bauer R., Kreis W. Enzymatic degradation of cichoric acid in Echinacea purpurea preparations. J Nat Prod 2000, 63:1615-1618.
109. Maier R., Carle R., Kreis W., Reinhard E. Purification and characterization of a flavone 7-O-glucoside-specific glucosidase from ligulate florets of Chamomilla recutita. Planta Med 1993, 59:436-441.
110. Kunle O.F., Egharevba H.O., Ahmadu P.O. Standardization of herbal medicines - a review. Int J Biodivers Conserv 2012, 4:101-112.
111. European Medicines Agency Guideline on quality of herbal medicinal products/ traditional herbal medicinal products http://www.gmp-compliance.org/guidemgr/files/2011_EMA_QUALITY_HERBAL_GUIDELINE.PDF.
112. Zeng Z., Chau F., Chan H., Cheung C., Lau T., Wei S., et al. Recent advances in the compound-oriented and pattern-oriented approaches to the quality control of herbal medicines. Chin Med 2008, 3:9.
113. Srinivasan V.S. Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program - a public health program. Life Sci 2006, 78:2039-2043.
114. Chan S.S.-K., Li S.-L., Lin G. Pitfalls of the selection of chemical markers of the quality control of medicinal herbs. J Food Drug Anal 2007, 15:365-371.
115. Li S., Han Q., Qiao C., Song J., Lung Cheng C., Xu H. Chemical markers for the quality control of herbal medicines: an overview. Chin Med 2008, 3:7.
116. van der Kooy Frank, Maltese F., Choi Y.H., Kim H.K., Verpoorte R. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med 2009, 75:763-775.
117. Xiong H., Yu L.X., Qu H. Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprint. AAPS PharmSciTech 2013, 14:802-810.
118. World Health Organization Guidelines for the assessment of herbal medicines http://whqlibdoc.who.int/HQ/1991/WHO_TRM_91.4.pdfhttp://whqlibdoc.who.int/HQ/1991/WHO_TRM_91.4.pdf.
119. Food and Drug Administration, Center for Drug Evaluation and Research Guidance for industry botanical drug products http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070491.pdf.
120. Goodarzi M., Russell P.J., Vander Heyden Y. Similarity analyses of chromatographic herbal fingerprints: a review. Anal Chim Acta 2013, 804:16-28.
121. Tistaert C., Dejaegher B., Vander Heyden Y. Chromatographic separation techniques and data handling methods for herbal fingerprints: a review. Anal Chim Acta 2011, 690:148-161.
122. Wolfender J., Rudaz S., Choi Y.H., Kim H.K. Plant metabolomics: from holistic data to relevant biomarkers. Curr Med Chem 2013, 20:1056-1090.
123. Gad H.A., El-Ahmady S.H., Abou-Shoer M.I., Al-Azizi M.M. Application of chemometrics in authentication of herbal medicines: a review. Phytochem Anal 2013, 24:1-24.
124. Liang Y., Xie P., Chau F. Chromatographic fingerprinting and related chemometric techniques for quality control of traditional Chinese medicines. J Sep Sci 2010, 33:410-421.
125. Shan S., Luo J., Huang F., Kong L. Chemical characteristics combined with bioactivity for comprehensive evaluation of Panax ginseng C.A. Meyer in different ages and seasons based on HPLC-DAD and chemometric methods. J Pharm Biomed Anal 2014, 89:76-82.
126. Jiang J., Zhang H., Zhou P., Han S., Han Y., Yuan Y. Composition-activity relationship modeling to predict the antitumor activity for quality control of curcuminoids from Curcuma longa L. (turmeric). Anal Methods 2013, 5:641.
127. Chen C., Li S., Wang S., Liang S. Multiple information contents derived from the chromatograms and their application to the modeling of quantitative profile-efficacy relationship. Anal Chim Acta 2012, 713:30-35.
128. Techen N., Crockett S.L., Khan I.A., Scheffler B.E. Authentication of medicinal plants using molecular biology techniques to compliment conventional methods. Curr Med Chem 2004, 11.
129. Zhao Z., Liang Z., Ping G. Macroscopic identification of Chinese medicinal materials: traditional experiences and modern understanding. J Ethnopharmacol 2011, 134:556-564.
130. de Boer Hugo J., Ouarghidi A., Martin G., Abbad A., Kool A. DNA barcoding reveals limited accuracy of identifications based on folk taxonomy. PLoS One 2014, 9:e84291.
131. The State Pharmacopoeia Commission of P.R. China Pharmacopoeia of the People's Republic of China 2010, China Medical Science Press.
132. American Herbal Pharmacopoeia: botanical pharmacognosy - microscopic characterization of botanical medicines 2011, American Herbal Pharmacopoeia/CRC Press, Boca Raton, FL. R. Upton, A. Graff, G. Jolliffe, R. Länger, E. Williamson (Eds.).
133. Wichtl M. Teedrogen und Phytopharmaka: Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage 2009, Wiss. Verl.-Ges, Stuttgart. 5th ed.
134. Zhao Z., Chen H. Chinese medicinal identification: an illustrated approach 2014, Paradigm Publications, Taos, N.M.
135. An illustrated microscopic identification of Chinese materia medica 2005, International Society for Chinese Medicine, Hong Kong. Z. Zhao (Ed.).
136. Heubl G. New aspects of DNA-based authentication of Chinese medicinal plants by molecular biological techniques. Planta Med 2010, 76:1963-1974.
137. Techen N., Parveen I., Pan Z., Khan I.A. DNA barcoding of medicinal plant material for identification. Curr Opin Biotechnol 2014, 25:103-110.
138. Plant DNA fingerprinting and barcoding: methods and protocols. Methods in molecular biology 2012, vol. 862. Humana Press, New York. N.J. Sucher, J.R. Hennell, M.C. Carles (Eds.).
139. Nybom H., Weisig K., Rotter B. DNA fingerprinting in botany: past, present, future. Investigative Genet 2014, 5:1.
140. Techen N., Pan Z., Scheffler B.E., Khan I.A. Detection of Illicium anisatum as adulterant of Illicium verum. Planta Med 2009, 75:392-395.
141. Appleby N., Edwards D., Batley J. New technologies for ultra-high throughput genotyping in plants. Gustafson JP, Langridge P, Somers DJ (Eds): Plant Genomics. Methods in Molecular Biology. New York. Humana Press 2009, 513:19-39.
142. Lee O.R., Kim M.K., Yang D.-C. Authentication of medicinal plants by SNP-based multiplex PCR. Methods in molecular biology 2012, vol. 862:135-147. Humana Press, New York. N.J. Sucher, J.R. Hennell, M.C. Carles (Eds.).
143. Hebert Paul D.N., Cywinska A., Ball S.L., deWaard J.R. Biological identifications through DNA barcodes. Proceedings. Biological sciences/The Royal Society 2003, 270:313-321.
144. CBOL Plant Working Group A DNA barcode for land plants. Proc Natl Acad Sci 2009, 106:12794-12797.
145. Nock C.J., Waters Daniel L.E., Edwards M.A., Bowen S.G., Rice N., Cordeiro G.M., et al. Chloroplast genome sequences from total DNA for plant identification. Plant Biotechnol J 2011, 9:328-333.
146. Sucher N.J., Hennell J.R., Carles M.C. DNA fingerprinting, DNA barcoding, and next generation sequencing technology in plants. Methods in molecular biology 2012, vol. 862:13-22. Humana Press, New York. N.J. Sucher, J.R. Hennell, M.C. Carles (Eds.).
147. Rohman A., Nugroho A., Lukitaningsih E., Sudjadi Application of vibrational spectroscopy in combination with chemometrics techniques for authentication of herbal medicine. Appl Spectrosc Rev 2014, 49:603-613.
148. Huck C.W. Advances of vibrational spectroscopic methods in phytomics and bioanalysis. J Pharm Biomed Anal 2014, 87:26-35.
149. Sun S., Chen J., Zhou Q., Lu G., Chan K. Application of mid-infrared spectroscopy in the quality control of traditional Chinese medicines. Planta Med 2010, 76:1987-1996.
150. Politi M., Zloh M., Pintado M.E., Castro Paula M.L., Heinrich M., Prieto J.M. Direct metabolic fingerprinting of commercial herbal tinctures by nuclear magnetic resonance spectroscopy and mass spectrometry. Phytochem Anal 2009, 20:328-334.
151. Yang H., Irudayaraj J. Comparison of near-infrared, fourier transform-infrared, and fourier transform-Raman methods for determining olive pomace oil adulteration in extra virgin olive oil. JAOCS 2001, 78:889-895.
152. Guo L.P., Huang L.Q., Zhang X.P., Bittner L., Pezzei C., Pallua J., et al. Application of near-infrared spectroscopy (NIRS) as a tool for quality control in Traditional Chinese Medicine (TCM). Curr Bioact Compd 2011, 7:75-84.
153. Huck-Pezzei V.A., Bittner L.K., Pallua J.D., Sonderegger H., Abel G., Popp M., et al. A chromatographic and spectroscopic analytical platform for the characterization of St John's wort extract adulterations. Anal Methods 2013, 5:616.
154. Cordell G.A. Sustainable medicines and global health care. Planta Med 2011, 77:1129-1138.
155. Sorak D., Herberholz L., Iwascek S., Altinpinar S., Pfeifer F., Siesler H.W. New developments and applications of handheld Raman, mid-infrared, and near-infrared spectrometers. Appl Spectrosc Rev 2012, 47:83-115.
156. Wolfender J., Marti G., Thomas A., Bertrand S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J Chromatogr A 2015, 1382:136-164.
157. 1H NMR spectroscopy and multivariate statistical analysis. J Pharm Biomed Anal 2014, 93:51-58.
158. Gilard V., Balayssac S., Tinaugus A., Martins N., Martino R., Malet-Martino M. Detection, identification and quantification by (1)H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal 2015, 102:476-493.
159. Liu Y., Chen S., McAlpine J.B., Klein L.L., Friesen J.B., Lankin D.C., et al. Quantification of a botanical negative marker without an identical standard: ginkgotoxin in Ginkgo biloba. J Nat Prod 2014, 77:611-617.
160. Simmler C., Napolitano J.G., McAlpine J.B., Chen S., Pauli G.F. Universal quantitative NMR analysis of complex natural samples. Curr Opin Biotechnol 2014, 25:51-59.
161. Chauthe S.K., Sharma R.J., Aqil F., Gupta R.C., Singh I.P. Quantitative NMR: an applicable method for quantitative analysis of medicinal plant extracts and herbal products. Phytochem Anal 2012, 23:689-696.
162. Pferschy-Wenzig E.M., Bauer R. Quality control of Chinese herbal drugs. Evaluation of herbal medicinal products: perspectives on quality, safety, and efficacy 2009, 393-425. Pharmaceutical Press, London. P. Houghton, P.K. Mukherjee (Eds.).
163. USP 37-NF 32 The United States Pharmacopeia and National Formulary 2014: main edition plus supplements 1 and 2 2013, Deutscher Apotheker Verlag, Stuttgart. 1st ed.
164. Wagner H., Bladt S. Plant drug analysis 1996, Springer, Berlin, Heidelberg.
165. Chinese Pharmacopoeia Commission TLC atlas of Chinese crude drugs in Pharmacopoeia of the People's Republic of China 2009, People's Pharmacopoeia Commission, Beijing.
166. Wagner H., Bauer R., Melchart D., Staudinger A., Xiao P. Chromatographic fingerprint analysis of herbal medicines: thin-layer and high performance liquid chromatography of Chinese drugs 2011, Springer-Verlag/Wien, Vienna.
167. Guiochon G. Monolithic columns in high-performance liquid chromatography. J Chromatogr A 2007, 1168:101-168.
168. Alpert A.J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr A 1990, 499:177-196.
169. Gama M.R., da Costa Silva Raquel Gomes, Collins C.H., Bottoli C.B. Hydrophilic interaction chromatography. TrAC Trends Anal Chem 2012, 37:48-60.
170. Petruczynik A., Waksmundzka-Hajnos M. Application of hydrophilic interaction chromatography in phytochemical analysis. Acta Chromatogr 2013, 25:1-25.
171. Jin Y., Liang T., Fu Q., Xiao Y., Feng J., Ke Y., et al. Fingerprint analysis of Ligusticum chuanxiong using hydrophilic interaction chromatography and reversed-phase liquid chromatography. J Chromatogr A 2009, 1216:2136-2141.
172. Eugster P.J., Guillarme D., Rudaz S., Veuthey J.-L., Carrupt P.-A., Wolfender J.-L. Ultra high pressure liquid chromatography for crude plant extract profiling. J AOAC Int 2011, 94:51-70.
173. Liang X., Jin Y., Wang Y., Jin G., Fu Q., Xiao Y. Qualitative and quantitative analysis in quality control of traditional Chinese medicines. J Chromatogr A 2009, 1216:2033-2044.
174. Vehovec T., Obreza A. Review of operating principle and applications of the charged aerosol detector. J Chromatogr A 2010, 1217:1549-1556.
175. 3 method for qualitative and quantitative standardization of polyphenols in Agrimoniae eupatoriae herba (Ph. Eur). J Pharm Biomed Anal 2013, 86:112-122.
176. Steinmann D., Ganzera M. Recent advances on HPLC/MS in medicinal plant analysis. J Pharm Biomed Anal 2011, 55:744-757.
177. Wu H., Guo J., Chen S., Liu X., Zhou Y., Zhang X., et al. Recent developments in qualitative and quantitative analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2013, 72:267-291.
178. Roullier C., Chollet-Krugler M., Pferschy-Wenzig E., Maillard A., Rechberger G.N., Legouin-Gargadennec B., et al. Characterization and identification of mycosporines-like compounds in cyanolichens. Isolation of mycosporine hydroxyglutamicol from Nephroma laevigatum Ach. Phytochemistry 2011, 72:1348-1357.
179. Feng X., Siegel M.M. FTICR-MS applications for the structure determination of natural products. Anal Bioanal Chem 2007, 389:1341-1363.
180. Hu Q., Noll R.J., Li H., Makarov A., Hardman M., Graham Cooks R. The Orbitrap: a new mass spectrometer. J Mass Spectrom 2005, 40:430-443.
181. Zhou J., Qi L., Li P. Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry. J Chromatogr A 2009, 1216:7582-7594.
182. Mao Q., Bai M., Xu J., Kong M., Zhu L., Zhu H., et al. Discrimination of leaves of Panax ginseng and P. quinquefolius by ultra high performance liquid chromatography quadrupole/time-of-flight mass spectrometry based metabolomics approach. J Pharm Biomed Anal 2014, 97:129-140.
183. Heng M.Y., Tan S.N., Yong J.W.H., Ong E.S. Emerging green technologies for the chemical standardization of botanicals and herbal preparations. TrAC Trends Anal Chem 2013, 50:1-10.
184. Tubaon R.M.S., Rabanes H., Haddad P.R., Quirino J.P. Capillary electrophoresis of natural products: 2011-2012. Electrophoresis 2014, 35:190-204.
185. Zhang Y., Chen Z. Nonaqueous CE ESI-IT-MS analysis of Amaryllidaceae alkaloids. J Sep Sci 2013, 36:1078-1084.
186. Dickschat J.S. Capturing volatile natural products by mass spectrometry. Nat Prod Rep 2014, 31:838-861.
187. Olejiniczak K., Günzel P., Bass R. Preclinical testing strategies. Drug Inf J 2001, 35:321-336.
188. Butterweck V., Nahrstedt A. What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med 2012, 78:747-754.
189. Patwardhan B., Mashelkar R.A. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?. Drug Discov Today 2009, 14:804-811.
190. Directive 2004/24/EC of the European Parliament and the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, directive 2001/83/EC on the community code relating to medicinal products for human use. Off J Eur Union 2004, L-136:85-90.
191. Directive 2001/83/EC of the European Parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use. Off J 2004, L-311:67-128.
192. Committee on herbal medicinal products Guideline on non-clinical documentation for herbal medicinal products in applications for marketing authorization (bibliographical and mixed applications) and in applications for simplified registration EMEA/HMPC/32116/2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003576.pdf.
193. Hermans N., Cos P., Maes L., De Bruyne T., Vanden Berghe D., Vlietinck A.J., et al. Challenges and pitfalls in antioxidant research. Curr Med Chem 2007, 14:417-430.
194. Cos P., Vlietinck A.J., Berghe D.V., Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol 2006, 106:290-302.
195. Agarwal A., D'Souza P., Johnson T.S., Dethe S.M., Chandrasekaran C. Use of in vitro bioassays for assessing botanicals. Curr Opin Biotechnol 2014, 25:39-44.
196. Simmen U., Saladin C., Kaufmann P., Poddar M., Wallimann C., Schaffner W. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort. Planta Med 2005, 71:592-598.
197. Hostanska K., Melzer J., Rostock M., Suter A., Saller R. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix. J Pharm Pharmacol 2014, 66:1606-1614.
198. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003, 41:631-636.
199. Ohtomo T., Uehara M., Peñalvo J.L., Adlercreutz H., Katsumata S., Suzuki K., et al. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur J Nutr 2008, 47:273-279.
200. Setchell Kenneth D.R., Clerici C. Equol: pharmacokinetics and biological actions. J Nutr 2010, 140:1363S-1368S.
201. Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005, 230:155-170.
202. Henrich C.J., Beutler J.A. Matching the power of high throughput screening to the chemical diversity of natural products. Nat Prod Rep 2013, 30:1284-1298.
203. Picker P., Vogl S., McKinnon R., Mihaly-Bison J., Binder M., Atanasov A.G., et al. Plant extracts in cell-based anti-inflammatory assays - pitfalls and considerations related to removal of activity masking bulk components. Phytochem Lett 2014, 10:xli.
204. Peng L., Wang B., Ren P. Reduction of MTT by flavonoids in the absence of cells. Colloids Surf B Biointerfaces 2005, 45:108-111.
205. Shoemaker M., Cohen I., Campbell M. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol 2004, 93:381-384.
206. Svedsen O. Ethics and animal welfare related to in vivo pharmacology and toxicology in laboratory animals. Basic Clin Pharmacol Toxicol 2005, 97:197-199.
207. Possemiers S., Bolca S., Verstraete W., Heyerick A. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 2011, 82:53-66.
208. Vissiennon C., Nieber K., Kelber O., Butterweck V. Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin - are they prodrugs?. J Nutr Biochem 2012, 23:733-740.
209. Gagnier J.J., Boon H., Rochon P., Moher D., Barnes J., Bombardier C. Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol 2006, 59:1134-1149.
210. Bansal D., Hota D., Chakrabarti A. Research methodological issues in evaluating herbal interventions. Open Access J Clin Trials 2010, 2:15-21.
211. Gagnier J.J., DeMelo J., Boon H., Rochon P., Bombardier C. Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med 2006, 119:800.e1-800.e11.
212. Linde K., Jonas W.B., Melchart D., Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001, 30:526-531.
213. Cameron M., Gagnier J.J., Chrubasik S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev 2011, CD002948.
214. Wolsko P.M., Solondz D.K., Phillips R.S., Schachter S.C., Eisenberg D.M. Lack of herbal supplement characterization in published randomized controlled trials. Am J Med 2005, 118:1087-1093.
215. Linde K., ter Riet G., Hondras M., Vickers A., Saller R., Melchart D., et al. Systematic reviews of herbal medicines - an annotated bibliography. Forsch Komplementarmed Klass Naturheilkd 2003, 10(Suppl. 1):17-27.
216. Gagnier J.J., Boon H., Rochon P., Moher D., Barnes J., Bombardier C., et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006, 144:364-367.